Table 2.
Element | Control group (n=8) | Low-dose group (n=8) | Medium-dose group (n=8) | High-dose group (n=8) | P |
---|---|---|---|---|---|
Whole blood (ng/mL) | |||||
Se | 386.69±44.82b,c,d | 762.05±163.43a | 1631.57±255.25a,d | 5351.87±1752.80a,b,c | <0.001 |
Cd | 1.48±1.82d | 2.93±1.88d | 14.55±4.55d | 99.69±45.19a,b,c | <0.001 |
Mo | 30.76±7.14c,d | 138.33±90.39c,d | 1073.95±416.29a,b,d | 4509.64±1417.70a,b,c | <0.001 |
Plasma (ng/mL) | |||||
Se | 158.77±14.74c,d | 236.35±39.42c,d | 412.48±50.71a,b,d | 695.41±138.07a,b,c | <0.001 |
Cd | 0.64±0.55d | 1.03±0.64d | 3.36±1.35d | 63.20±30.10a,b,c | <0.001 |
Mo | 20.36±5.06d | 101.28±62.26d | 685.86±252.18d | 4230.80±1497.40a,b,c | <0.001 |
RBCs (ng/g) | |||||
Se | 440.16±81.40d | 834.78±171.76d | 2377.03±815.96d | 8539.23±3112.16a,b,c | <0.001 |
Cd | 1.87±0.84d | 6.22±1.57d | 22.07±7.44d | 108.84±49.18a,b,c | <0.001 |
Mo | 6.15±2.30c,d | 9.76±3.57c,d | 62.52±36.87a,b,d | 228.33±62.59a,b,c | <0.001 |
PBMCs (ng/106 cells) | |||||
Se | 1.67±0.45b,c,d | 3.44±1.25a | 4.44±2.78a | 4.83±1.58a | 0.005 |
Cd | 0.11±0.05d | 0.08±0.04d | 0.16±0.10d | 0.21±0.10a,b | 0.014 |
Mo | 0.65±0.37 | 0.65±0.31 | 0.82±0.53 | 0.93±0.53 | 0.528 |
Represents statistical significance (P<0.05) compared to the control group.
Represents statistical significance (P<0.05) compared to the low-dose group.
Represents statistical significance (P<0.05) compared to the medium-dose group.
Represents statistical significance (P<0.05) compared to the high-dose group.